Cellular immunity in people resistant to HCV infection.

被引:0
|
作者
Freeman, AJ [1 ]
Post, JJ [1 ]
Harvey, CE [1 ]
Pan, Y [1 ]
White, PA [1 ]
Marinos, G [1 ]
Rawlinson, WD [1 ]
Ffrench, R [1 ]
Lloyd, AR [1 ]
机构
[1] Univ New S Wales, Sydney, NSW, Australia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
401
引用
收藏
页码:263A / 263A
页数:1
相关论文
共 50 条
  • [1] Cellular and humoral immunity in patients who have spontaneously cleared HCV infection.
    Zitron, IM
    Qu, S
    Laurinaitis, M
    Silverman, AL
    Gordon, SC
    HEPATOLOGY, 2000, 32 (04) : 267A - 267A
  • [2] FIV model for evaluating cellular immunity against lentiviral infection.
    Pu, R
    Pollock, D
    Arai, M
    Yamamoto, JK
    FASEB JOURNAL, 1999, 13 (04): : A295 - A295
  • [3] Telaprevir for Chronic HCV Infection.
    van der Meer, Adriaan J. P.
    de Knegt, Robert J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (05): : 533 - 534
  • [4] Vigorous and broadly-directed cellular immune response in acute HCV infection.
    Wong, DKH
    Dohrenwend, PB
    Rosenberg, ES
    Chung, RT
    Robbins, GK
    Walker, BD
    HEPATOLOGY, 1998, 28 (04) : 274A - 274A
  • [5] Peripheral cellular immune responses during rebetron therapy for chronic HCV infection.
    Zitron, IM
    Qu, S
    Silverman, AL
    Gordon, SC
    HEPATOLOGY, 2000, 32 (04) : 374A - 374A
  • [6] HCV core antigen: A new marker of HCV infection.
    Bouvier-Alias, M
    Patel, K
    Beaucourt, S
    Larderie, P
    Blatt, LM
    Dhumeaux, D
    McHutchison, JG
    Pawlotsky, JM
    HEPATOLOGY, 2001, 34 (04) : 227A - 227A
  • [7] Mucosal Immunity in Cervicovaginal Infection.
    Nold, Christopher J.
    Maubert, Monique
    Anton, Lauren
    Elovitz, Michal
    REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 297A - 298A
  • [8] Immunogenetic markers and the course of HCV infection.
    Lio, D
    Almasio, PL
    Romano, GC
    Candore, G
    Valenza, ML
    Di Pisa, M
    D'Antona, F
    Ferraro, D
    Caruso, C
    Craxi, A
    HEPATOLOGY, 2000, 32 (04) : 273A - 273A
  • [9] Thrombocytopenia associated with HCV viral infection.
    Loustaud-Ratti, V
    Riche, A
    Jauberteau, MO
    Soria, P
    Liozon, E
    Ranger, S
    Labrousse, F
    Vidal, E
    HEPATOLOGY, 1999, 30 (04) : 591A - 591A
  • [10] Effect of HCV infection on the prognosis of hemophiliacs with HIV infection.
    Seto, Y
    Higasa, S
    Yoshimoto, H
    Ueda, M
    Kuroiwa, T
    Nakamura, Y
    Iwata, N
    Suehiro, A
    Kakishita, E
    HEPATOLOGY, 1998, 28 (04) : 293A - 293A